Skip to content

Omeros OMER Operating margin

Discontinued — last reported Q3 '21

Operating margin at other companies

Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-242%
Immunome logo
ImmunomeIMNM
-5,947.9%-12,002pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-168.6%-52.7pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-4,558.4%-9,354pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
17.6%+9.6pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-39,428.9%-49,795pp

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$775.86M+313%
P/S8.6×

Profitability

See full
Gross margin98.9%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

Based on trailing twelve months.

The official record: Omeros’s 10-Q, filed November 9, 2021, on SEC EDGAR. View the filing →

Ask your AI about Omeros's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's operating margin?
Omeros (OMER) reported operating margin of -181.8% in Q3 2021.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.